BMO Capital Upgrades TrueBlue to Outperform, Raises Price Target to $20
Portfolio Pulse from richadhand@benzinga.com
BMO Capital analyst Jeffrey Silber upgrades TrueBlue (NYSE:TBI) from Market Perform to Outperform and raises the price target from $18 to $20.
May 22, 2023 | 10:36 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
TrueBlue (NYSE:TBI) has been upgraded to Outperform by BMO Capital, with a raised price target of $20.
The upgrade from Market Perform to Outperform and the raised price target from $18 to $20 by BMO Capital analyst Jeffrey Silber indicate a positive outlook for TrueBlue. This is likely to have a positive short-term impact on the stock price as investors may see this as a sign of increased confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100